Showing results (141-150 of 227) with videos related to
Sort By:
Pageof 23
The AAPS Journal|July 4, 2020
Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects ModelsHenrik Bjugård Nyberg, Andrew C Hooker, Robert J Bauer, et al.The AAPS Journal|July 16, 2011
Optimal design in population kinetic experiments by set-valued methodsPeter Gennemark, Alexander Danis, Joakim Nyberg, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 26, 2009
Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental designHanna E Silber, Joakim Nyberg, Andrew C Hooker, et al.Malaria Journal|May 4, 2012
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.British Journal of Clinical Pharmacology|August 14, 2008
Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infectionJuliana F Roos, Carl M J Kirkpatrick, Susan E Tett, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2014
Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep modelC Steven Ernest, Joakim Nyberg, Mats O Karlsson, et al.CPT: Pharmacometrics & Systems Pharmacology|November 10, 2023
Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIVGrace Montepiedra, Elin M Svensson, Weng Kee Wong, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 15, 2011
Modeling red blood cell survival dataJulia Korell, Frederiek E Vos, Carolyn V Coulter, et al.British Journal of Clinical Pharmacology|July 18, 2006
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulationYan Feng, Bruce Green, Stephen B Duffull, et al.Therapeutic Drug Monitoring|December 1, 2004
Sampling times for monitoring tacrolimus in stable adult liver transplant recipientsChantaratsamon Dansirikul, Christine E Staatz, Stephen B Duffull, et al.Pageof 23